{{Rsnum
|rsid=12615435
|Gene=FTCDNL1
|Chromosome=2
|position=199773786
|Orientation=plus
|GMAF=0.09917
|Gene_s=FTCDNL1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 0.0 | 11.5 | 88.5
| HCB | 3.6 | 29.9 | 66.4
| JPT | 2.7 | 33.6 | 63.7
| YRI | 0.0 | 6.8 | 93.2
| ASW | 0.0 | 7.0 | 93.0
| CHB | 3.6 | 29.9 | 66.4
| CHD | 5.5 | 28.4 | 66.1
| GIH | 0.0 | 5.9 | 94.1
| LWK | 0.9 | 10.0 | 89.1
| MEX | 3.4 | 17.2 | 79.3
| MKK | 0.0 | 10.9 | 89.1
| TSI | 1.0 | 14.7 | 84.3
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23648065
  |Trait=Adverse response to chemotherapy (neutropenia/leucopenia) (all anthracycline-based drugs)
  |Title=Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.
  |RiskAllele=T
  |Pval=4E-6
  |OR=2.21
  |ORtxt=[1.555-3.154]
  }}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}